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Letters
Prostatitis and Benign Prostatic
Hyperplasia: Emerging Infectious
Diseases?
To the Editor: In their excellent article,
Molecular Approaches to the Identification of
Unculturable Infectious Agents, Gao and Moore
(1) point out that molecular approaches should be
unleashed on diseases such as sarcoidosis, Kawa-
saki disease, and type I diabetes mellitus, which
are thought but not proven to be infectious. The
authors, however, are overlooking the more com-
mon and most likely infectious disease of unknown
etiology today—prostatitis.
According to the pathologist McNeal, the
prostate gland is the most commonly diseased
internal organ of the human body (2). Prostatitis
is the most common prostate disease, resulting in
more physician visits than either benign pros-
tatic hyperplasia or prostate cancer, according to
the National Institutes of Health (3). Despite its
frequency, prostatitis as a disease and as a histo-
logic lesion is understudied (4).
By the Meares and Stamey culture localization
procedure, in which the first voided urine, a mid-
stream urine, the expressed prostatic secretions,
and a final voided urine are compared, more than
90% of cases in patients with chronic pelvic symp-
toms are labeled as “nonbacterial” prostatitis or
prostatodynia, both of which are thought to be
incurable diseases (5).
The University of Washington has documented
white blood cell counts as high as 38,000 per mm3,
in “nonbacterial” prostatitis patients (6). Accord-
ing to urologist Thomas Stamey, up to 50% of all
men experience symptoms of prostatitis during
Emergence of Epidemic O’nyong-
nyong Fever in Southwestern Uganda,
After an Absence of 35 Years
To the Editor: In July 1996, an uncommon disease
suspected to be O’nyong-nyong fever was recog-
nized in the Rakai district of southwestern Uganda.
It was reported to have started in June 1996. The
disease spread into the neighboring Mbarara and
Masaka districts of Uganda and in the bordering
Bukoba district of northern Tanzania.
The initial symptoms of O’nyong-nyong fever
are high fever and generalized maculopapular
skin rash with crippling arthritis, primarily in the
big joints, in the absence of joint effusion. Other
features are lymphadenitis, eye pain and
reddening with no discharge, chest pain, and
general malaise. The disease is self-limiting. All
age groups and both sexes are equally affected. In
areas where the disease is epidemic, 60% to 80%
of the people are infected, and familial clustering
is found in affected households. No deaths have
been reported, but two miscarriages have been
associated with infection.
The Ministry of Health (Uganda), in
collaboration with the Uganda Virus Research
Institute, began epidemiologic and clinical inves-
tigations of the epidemic in August 1996. Acute-
phase serum samples were collected from
patients, and adult mosquitoes were collected
from within and around patients’ homes. Virus
isolates were made from acute-phase serum
samples from several patients by intracranial
inoculation and passage in baby mice. Attempted
virus isolations from mosquito specimens are in
progress. Serum samples and aliquots of the
virus isolates were sent to the Centers for
Disease Control and Prevention, Fort Collins,
Colorado, USA, for reisolation and identification.
A portion of the capside and NS4  genes of the
virus isolates was sequenced and identified as
O’nyong-nyong virus; the virus was isolated and
sequenced directly from another serum sample.
Two serum samples were positive for IgM
antibody to O’nyong-nyong antigen.
O’nyong-nyong virus was responsible for a
similar epidemic in 1959 to 1961, which started
in northern Uganda and spread south and
eastward into Kenya, Tanzania, and Zambia, and
then northward from Tanzania into southwestern
Uganda, where it subsided. The disease has
reemerged in this area after 35 years of absence.
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